Hypoparathyroidism

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 6, 1997, Pages 427-432

  Bilezikian, John P ^a   Thakker, R V ^b  

^a Columbia University ^*  (United States)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000445840     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199712000-00008     Document Type: Article

References (47)

1. Thakker RV: The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol 1993, 38:1-14.
2. Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM: Mutations of the signal peptide encoding region of preproparathyroid hormone gene in isolated hypoparathyroidism. J Clin Invest 1990, 86:1084-1087.
3. Karaplis AC, Lim SC, Baba H, Arnold A, Kronenberg HM: Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 1995, 27:1629-1635. Excellent study demonstrating the molecular mechanisms and consequences of a mutation in the signal sequence of the PTH gene that results in autosomal dominant hypoparathyroidism.
4. Parkinson DB, Thakker RV: A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1992, 1:149-153.
5. Chelly J, Concordet J-P, Kaplan J-C, Kahn A: Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A 1989, 86:2617-2621.
6. Sarkar G, Sommer SS: Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 1989, 244:331-334.
7. Thakker RV, Davies KE, Whyte MP, Wooding C, O'Riordan JLH: Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest 1990, 86:40-45.
8. Dixon PH, Trump D, Wooding C, Mumm S, Schlessinger D, Whyte MP, Thakker RV: Genetic mapping studies of the X-linked recessive hypoparathyroid gene on the X chromosome (Xq27). J Bone Miner Res 1996, 11:S137.
9. Zucchi I, Mumm S, Pilia G, MacMillan S, Reinbold R, Susani L, Weissenbach J, Schlessinger D: YAC/STS map across 12 Mb of Xq27 at 25 Kb resolution, merging Xq26-qter. Genomics 1996, 34:42-54.
10. Mumm S, Whyte MP, Thakker RV, Buetowk H, Schlessinger D: mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation. Am J Hum Genet 1997, 1:153-159.
11. Ahonen P, Myllamiemi S, Sipila I, Perheentupa J: Clinical variation of autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990, 322:1829-1836.
12. Ahonen P: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 1985, 27:535-542.
13. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L: An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type 1 assigned to chromosome 21. Nat Genet 1994, 8:83-87.
14. Zlotogora J, Shapiro MS: Polyglandular autoimmune syndrome type 1 among Iranian Jews. J Med Genet 1992, 29:824-826.
15. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S: Mitochondrial deletions in progressive external ophthaimoplegia and Kearns-Sayre syndrome. N Engl J Med 1989, 320:1293-1299.
16. Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S: Deletions of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 1991, 29:680-683.
17. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J: A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993, 2:2081-2087.
18. Isotani H, Fukumoto Y, Kawamura H, Furukawa K, Ohsawa N, Goto Y, Nishino I, Nonaka I: Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion. Clin Endocrinol 1996, 45:637-641.
19. Wilichowski E, Gruters A, Kruse K, Rating D, Beetz R, Korenke GC, Ernst BP, Christen HJ, Hanefeld F: Hypoparathyroidism and deafness associ-ated with pleioplasmic large scale rearrangements of the mitochondrial DNA. a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Paediatr Res 1997, 41:193-200.
20. Abramowicz MJ. Cochaux P, Cohen LHF, Vamos E: Pernicious anaemia and hypoparathyroidism in a patient with Kearns-Sayre syndrome with mitochondrial DNA duplication. J Inherit Metab Dis 1996 19:109-111.
21. Dionisi-Via C, Garavaglia B, Burlina AB, Bertini E, Saponara I, Sabetta G, Taroni F: Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr 1996, 129:159-162.
22. Scambler PJ, Carey AH, Wyse RKH, Roach S, Dumanski JP, Nordenskjold M, Williamson R: Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991, 10:201-206.
23. Monaco G, Pignata C, Rossi E, Mascellaro O, Cocozza S, Ciccimarra F: DiGeorge anomaly associated with 10p deletion. Am J Med Genet 1991, 39:215-216.
24. Halford S, Wilson DI, Dow SCM, Roberts C, Wadey R, Kamath S, Wickremasinghe A, Burn J, Goodship J, Mattei M-G, et al.: Isolation of a gene expressed during early embryogenesis from the region 22q11 containing deletions in DiGeorge syndrome. Hum Mol Genet 1993, 2:1577-1582.
25. Aubry K, Demczuk S, Desmaze C, Aikem M, Aaurias A, Julien J P, Rouleau GA: Isolation of a zinc finger gene consistently deleted in DiGeorge syndrome. Hum Mol Genet 1993, 2:1583-1587.
26. Kurahashi H, Akagi K, Inazawa J, Ohta T, Niikawa N, Kayatani F, Sano T, Okada S, Nishisho I: Isolation and characterization of a novel gene deleted in DiGeorge syndrome. Hum Mol Genet 1995, 4:541-549.
27. Wadey R, Daw S, Taylor C, Atif V, Kamath S, Halford S, O'Donnell H, Wilson D, Goodship J, Burn J: Isolation of a gene encoding an integral membrane protein from the vicinity of a balanced translocation breakpoint associated with DiGeorge syndrome. Hum Mol Genet 1995, 4:1027-1033.
28. Gong W, Emanuel BS, Collins J, Kim DH, Wang Z, Chen F, Zhang G, Roe B, Budarf ML: A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet 1996, 5:789-800.
29. Augusseau S, Jouk S, Jalbert P, Prieur M: DiGeorge syndrome and 22q11 rearrangements. Hum Genet 1986, 74:206.
30. Budarf ML, Collins J, Gong W, Roe B, Wang Z, Bailey LC, Sellinger B, Michaud D, Driscoll DA, Emanuel BS: Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 1995, 10:269-278. Excellent study identifying the mex40 and nex2.2-nex3.3 genes that are involved in the translocation of chromosome 22q11.21 in patients with DGS.
31. Bassett JDH, Thakker RV: Molecular genetics of disorders of calcium homeostasis. In Ballière's Clinical Endocrinology and Metabolism. Edited by Thakker RV. London: Ballière Tindall; 1995:581-608.
32. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993, 75:1297-1303.
33. 2+-sensing receptor gene that cause familial hypocalciuric hypercalcaemia. Am J Hum Genet 1995, 56:1075-1079.
34. Pearce SHS, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, Thakker RV: Calcium-sensing receptor mutations in familial benign hypercalcaemia and neonatal hyperparathyroidism. J Clin Invest 1995, 96:2683-2692. Diversity of mutations of CaR in familial benign hypercalcemia and neonatal hyperparathyroidism are reported, as well as the first report of de novo heterozygous mutations in neonatal hyperparathyroidism. Reports on the use of single-strand conformational polymorphism as a reliable method to detect such CaR mutations.
35. 2+-sensing receptor gene in familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995, 56:880-886.
36. 2+-sensing receptor gene. J Clin Endocrinol Metab 1995, 80:2594-2598.
37. Heath H III, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NRM, Krapcho KJ, Hung BC, Capuano IV, et al.: Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcaemia suggest receptor functional domains. J Clin Endocrinol Metab 1996, 81:1312-1317. Comprehensive report of CaR mutations and their functional effects.
38. Pollak MR Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG: Autosomal dominant hypocalcaemia caused by a calcium-sensing receptor gene mutation. Nat Genet 1994, 8:303-307.
39. Finegold DN, Armitage MM, Galiani M, Matise TC, Pandian MR, Perry YM, Deka R, Ferrell RE: Preliminary localisation of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 1994, 36:414-417.
40. Perry YM, Finegold DN, Armitage MM, Ferrell RE: A missense mutation in the Ca-sensing receptor causes familial autosomal dominant hypoparathyroidism. Am J Hum Genet 1994, 55-A17.
41. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, et al.: A familial syndrome of hypocalcaemia with hypocalciuria due to mutations In the calcium-sensing receptor gene. N Engl J Med 1996, 335:1115-1122. Reports on the association between activating CaR mutations and hypocalcemic hypercalciuria, and their potential use in distinguishing such patients from those with hypoparathyroidism.
42. Baron J, Winer KK, Yanovski JA, Cunningham AW, Laue L, Zimmerman D, Cutler GB Jr: Mutations in the Ca2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996, 5:601-606.
43. Yu S, Yu D, Hainline BE, Brener JL, Wilson KA, Wilson LC, Oude-Luttikhuis ME, Trembath RC, Weinstein LS: A deletion hot-spot in exon 7 of the G,α gene (GNAS1 ) in patients with Albright hereditary osteodystrophy. Hum Mol Genet 1995, 4:2001-2002.
44. Shapira H, Mouallem M, Shapiro MS, Weisman Y, Farfel Z: Pseudohypoparathyroidism type la: two new heterozygous frameshift mutations in exons 5 and 10 of the GSα gene. Hum Genet 1996, 97:73-75.
45. Spiegel AM: Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996, 81:2434-2442.
46. Dixon PH, Ahmed SF, Bonthron DT, Barr DGD, Kelnar CJH, Thakker RV: Mutational analysis of the GNAS1 gene in pseudohypoparathyroidism. J Bone Miner Res 1996, 11 (suppl):S729.
47. Schipani E, Weinstein LS, Bergwitz C, lida-Klein A, Kong XF, Stuhrmann M, Kruse K, Whyte MP, Murray T, Schmidtke J, et al.: Pseudohypoparathyroidism type lb Is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 1995, 80:1611-1621.